Amicus Therapeutics Inc. (FOLD)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

9.48

1.34%

After-hours Dec 13, 2024, 05:55 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03
Revenue	399.36M	329.23M	305.51M	260.89M	182.24M	91.25M	36.93M	4.96M	-	1.22M	363.00K	18.41M	21.43M	922.00K	64.36M	14.97M	1.78M	-	-	-	-
Cost of Revenue	37.33M	38.60M	34.47M	31.04M	21.96M	14.40M	6.24M	833.00K	1.83M	-	13.49M	20.38M	-	-	-	-	-	-	-	-	-
Gross Profit	362.03M	290.63M	271.05M	229.84M	160.27M	76.84M	30.69M	4.13M	-1.83M	1.22M	-13.13M	-1.97M	21.43M	922.00K	64.36M	14.97M	1.78M	-	-	-	-
Operating Income	-73.49M	-204.43M	-199.92M	-243.85M	-300.74M	-328.78M	-441.99M	-181.89M	-130.44M	-68.70M	-64.18M	-52.93M	-50.89M	-55.84M	-7.35M	-43.96M	-45.80M	-46.86M	-20.83M	-8.81M	-6.60M
Interest Income	7.08M	3.02M	509.00K	3.23M	10.25M	10.46M	4.10M	1.60M	929.00K	223.00K	174.00K	316.00K	160.00K	156.00K	997.00K	4.82M	-	1.99M	609.52K	-	5.00K
Pretax Income	-150.10M	-242.04M	-241.55M	-274.25M	-355.91M	-349.09M	-449.12M	-203.78M	-132.12M	-70.04M	-63.15M	-52.03M	-48.04M	-56.08M	-6.57M	-39.35M	-41.17M	-46.34M	-20.58M	-	-6.77M
Net Income	-151.58M	-236.57M	-250.46M	-276.85M	-356.39M	-349.00M	-284.00M	-200.04M	-132.12M	-68.93M	-59.63M	-48.78M	-44.41M	-54.94M	-6.57M	-39.35M	-41.17M	-46.34M	-19.97M	-8.81M	-6.77M
Selling & General & Admin	275.27M	213.04M	192.71M	156.41M	169.86M	127.20M	88.67M	71.15M	47.27M	20.72M	18.89M	19.36M	19.88M	15.66M	19.97M	19.67M	15.28M	12.28M	6.88M	-	-
Research & Development	152.38M	276.68M	272.05M	308.44M	286.38M	270.90M	149.31M	104.79M	76.94M	47.62M	41.94M	50.27M	50.86M	39.04M	48.08M	37.76M	31.07M	33.63M	13.65M	-	4.43M
Other Expenses	-	5.34M	6.21M	8.85M	4.78M	-5.63M	6.01M	-4.79M	-80.00K	-77.00K	1.72M	21.00K	1.58M	2.06M	2.13M	1.49M	1.24M	-	-	-8.81M	-
Operating Expenses	427.65M	495.06M	470.97M	473.70M	461.01M	402.32M	241.57M	179.19M	126.05M	69.89M	62.56M	71.34M	72.32M	56.76M	70.19M	58.92M	47.59M	46.86M	20.83M	-8.81M	6.60M
Interest Expense	50.15M	37.12M	32.47M	22.43M	18.87M	22.40M	17.24M	5.40M	1.58M	1.48M	46.00K	89.00K	148.00K	260.00K	278.00K	218.00K	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	472.85M	533.66M	505.43M	504.74M	482.98M	416.72M	247.81M	180.02M	126.05M	69.89M	62.56M	71.34M	72.32M	56.76M	70.19M	58.92M	47.59M	46.86M	20.83M	-8.81M	6.60M
Income Tax	1.48M	-5.47M	8.91M	2.60M	478.00K	-94.00K	-165.12M	-3.74M	1.50M	-1.11M	-3.51M	-3.25M	-3.63M	-1.14M	278.00K	-	351.00K	-514.36K	-611.80K	8.81M	-
Shares Outstanding (Basic)	295.16M	289.06M	271.42M	258.87M	240.42M	185.79M	153.36M	134.40M	109.92M	74.44M	51.29M	45.57M	34.57M	27.73M	22.62M	22.49M	13.24M	735.97K	410.22K	307.54K	307.54K
Shares Outstanding (Diluted)	295.16M	289.06M	271.42M	258.87M	240.42M	185.79M	153.36M	134.40M	109.92M	74.44M	51.29M	45.57M	34.57M	27.73M	22.62M	22.49M	13.24M	735.97K	410.22K	307.54K	307.54K
EPS (Basic)	-0.51	-0.82	-0.92	-1.07	-1.48	-1.88	-1.85	-1.49	-1.2	-0.93	-1.16	-1.07	-1.28	-1.98	-0.29	-1.75	-3.11	-62.97	-48.69	-28.64	-22.01
EPS (Diluted)	-0.51	-0.82	-0.92	-1.07	-1.48	-1.88	-1.85	-1.49	-1.2	-0.93	-1.16	-1.07	-1.28	-1.98	-0.29	-1.75	-3.11	-62.97	-48.69	-28.64	-22.01
EBITDA	-92.08M	-199.58M	-202.87M	-242.98M	-332.26M	-322.47M	-428.29M	-195.14M	-128.71M	-67.01M	-61.38M	-50.24M	-46.54M	-53.76M	-4.16M	-37.64M	-44.57M	-44.70M	-20.20M	-8.81M	-6.47M
Depreciation & Amortization	7.87M	5.34M	6.21M	8.85M	4.78M	4.22M	3.59M	3.24M	1.83M	1.55M	1.72M	1.71M	1.58M	2.06M	2.13M	1.49M	1.24M	952.45K	667.38K	-	132.00K